Taoyuan, Taiwan

Kar-Yee Yu

This inventor holds 1 USPTO granted patent. Top assignees: Chang Gung Memorial Hospital, Linkou, Chang Gung University. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Kar-Yee Yu

Introduction

Kar-Yee Yu is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of immunology, particularly in relation to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). His innovative methods have the potential to enhance our understanding of immune responses to this virus.

Latest Patents

Kar-Yee Yu holds a patent for a method that determines immune competence against SARS-CoV-2. This method involves obtaining a blood sample from a subject, detecting levels of binding antibodies against the SARS-CoV-2 spike S1 protein and its receptor binding domain (RBD), and calculating a weighted value using a regression model. This patent represents a crucial advancement in the assessment of immune responses to COVID-19.

Career Highlights

Throughout his career, Kar-Yee Yu has worked with prestigious institutions such as Chang Gung University and Chang Gung Memorial Hospital in Linkou. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to important research initiatives.

Collaborations

One of his notable collaborators is Kuan-Ting Liu. Their partnership has likely fostered innovative research and development in the field of immunology.

Conclusion

Kar-Yee Yu's contributions to the field of immunology, particularly through his patent on determining immune competence against SARS-CoV-2, highlight his role as an influential inventor. His work continues to impact the scientific community and advance our understanding of viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…